300434 金石亚药
已收盘 09-17 15:00:00
资讯
新帖
简况
突发异动！300434，3分钟直线20%涨停！创新药，集体爆发！
同花顺 · 10:32
突发异动！300434，3分钟直线20%涨停！创新药，集体爆发！
股市必读：金石亚药（300434）9月11日披露最新机构调研信息
证券之星 · 09-14
股市必读：金石亚药（300434）9月11日披露最新机构调研信息
金石亚药：9月11日召开业绩说明会，投资者参与
证券之星 · 09-11
金石亚药：9月11日召开业绩说明会，投资者参与
金石亚药（300434）披露将参加四川辖区2026年投资者网上集体接待日及半年度报告业绩说明会活动，9月8日股价上涨0.36%
证券之星 · 09-08
金石亚药（300434）披露将参加四川辖区2026年投资者网上集体接待日及半年度报告业绩说明会活动，9月8日股价上涨0.36%
股市必读：金石亚药新发布《关于董事减持计划期限届满的公告》
证券之星 · 09-04
股市必读：金石亚药新发布《关于董事减持计划期限届满的公告》
金石亚药（300434）披露董事减持计划期限届满公告，9月2日股价上涨0.53%
证券之星 · 09-02
金石亚药（300434）披露董事减持计划期限届满公告，9月2日股价上涨0.53%
金石亚药：8月31日董事郑志勇减持股份合计5万股
证券之星 · 09-01
金石亚药：8月31日董事郑志勇减持股份合计5万股
金石亚药：8月28日董事郑志勇减持股份合计15万股
证券之星 · 08-31
金石亚药：8月28日董事郑志勇减持股份合计15万股
金石亚药（300434）2026年中报简析：净利润同比增长45.22%，盈利能力上升
证券之星 · 08-27
金石亚药（300434）2026年中报简析：净利润同比增长45.22%，盈利能力上升
图解金石亚药中报：第二季度单季净利润同比下降809.77%
证券之星 · 08-25
图解金石亚药中报：第二季度单季净利润同比下降809.77%
金石亚药(300434)6月30日股东户数2.91万户，较上期增加21.53%
证券之星 · 08-25
金石亚药(300434)6月30日股东户数2.91万户，较上期增加21.53%
金石亚药：8月7日董事郑志勇减持股份合计25万股
证券之星 · 08-10
金石亚药：8月7日董事郑志勇减持股份合计25万股
股市必读：金石亚药新发布《关于子公司参与第十二批全国药品集中采购拟中选的公告》
证券之星 · 08-05
股市必读：金石亚药新发布《关于子公司参与第十二批全国药品集中采购拟中选的公告》
金石亚药：续断壮骨胶囊属于国家中药二类新药
证券之星 · 08-04
金石亚药：续断壮骨胶囊属于国家中药二类新药
金石亚药（300434）披露放弃参股公司增资优先认购权暨关联交易公告，7月17日股价下跌7.62%
证券之星 · 07-17
金石亚药（300434）披露放弃参股公司增资优先认购权暨关联交易公告，7月17日股价下跌7.62%
股市必读：金石亚药（300434）预计2026年1-6月扣非后净利润盈利7612.6万元至9861.96万元
证券之星 · 07-15
股市必读：金石亚药（300434）预计2026年1-6月扣非后净利润盈利7612.6万元至9861.96万元
金石亚药（300434）披露2026年半年度业绩预告，7月14日股价下跌0.75%
证券之星 · 07-14
金石亚药（300434）披露2026年半年度业绩预告，7月14日股价下跌0.75%
金石亚药：创业板上市公司半年度业绩预告无强制披露要求
证券之星 · 07-14
金石亚药：创业板上市公司半年度业绩预告无强制披露要求
金石亚药：目前，公司没有上述产品的获批事项
证券之星 · 07-06
金石亚药：目前，公司没有上述产品的获批事项
6月29日金石亚药（300434）涨停分析：医保目录预期、FDA获批驱动
证券之星 · 06-29
6月29日金石亚药（300434）涨停分析：医保目录预期、FDA获批驱动
加载更多
公司概况
公司名称：
四川金石亚洲医药股份有限公司
所属行业：
医药制造业
上市日期：
2015-04-24
主营业务：
四川金石亚洲医药股份有限公司的主营业务是药品及保健食品研发、生产以及销售。公司的主要产品是呼吸系统用药、其他医药健康产品、保健品及食品等领域。公司获得了“最受药店欢迎的明星单品”奖、浙江快克荣获“第二十届中国品牌节TopBrand2026中国品牌500强”等荣誉。
发行价格：
10.57
{"stockData":{"symbol":"300434","market":"SZ","secType":"STK","nameCN":"金石亚药","latestPrice":12.49,"timestamp":1789628631000,"preClose":10.41,"halted":0,"volume":45118582,"delay":0,"changeRate":0.1998,"floatShares":343000000,"shares":401999999,"eps":0.4017,"marketStatus":"已收盘","change":2.08,"latestTime":"09-17 15:00:00","open":10.53,"high":12.49,"low":10.45,"amount":552000000,"amplitude":0.196,"askPrice":0,"askSize":0,"bidPrice":12.49,"bidSize":20743,"shortable":0,"etf":0,"ttmEps":0.4017,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789695000000},"marketStatusCode":5,"adr":0,"adjPreClose":10.41,"symbolType":"stock","openAndCloseTimeList":[[1789608600000,1789615800000],[1789621200000,1789628400000]],"highLimit":11.45,"lowLimit":9.37,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401743872,"isCdr":false,"pbRate":1.6,"roa":"--","peRate":31.092855,"roe":"3.67%","epsLYR":0.33,"committee":0,"marketValue":5018000000,"turnoverRate":0.1314,"status":0,"floatMarketCap":4289000000},"requestUrl":"/m/hq/s/300434","defaultTab":"news","newsList":[{"id":"2668047930","title":"突发异动！300434，3分钟直线20%涨停！创新药，集体爆发！","url":"https://stock-news.laohu8.com/highlight/detail?id=2668047930","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668047930?lang=zh_cn&edition=full","pubTime":"2026-09-17 10:32","pubTimestamp":1789612320,"startTime":"0","endTime":"0","summary":"9月17日，A股主要指数集体低开。盘面上，视频媒体、房产租赁经纪、玻纤制造等板块涨幅居前，MLCC概念、贵金属、风电设备、油气开采等板块跌幅居前。创新药概念股走强创新药板块短线走高，金 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260917/c680001119.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260917/c680001119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0028","300434","159992","BK1574","BK0077","BK0239","IBBQ","06978","MEDX","LNGR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667063882","title":"股市必读：金石亚药（300434）9月11日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2667063882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667063882?lang=zh_cn&edition=full","pubTime":"2026-09-14 02:54","pubTimestamp":1789325652,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，金石亚药报收于10.11元，下跌2.88%，换手率3.3%，成交量11.31万手，成交额1.14亿元。公司2026年上半年归母净利润为9,547.42万元，同比增长45.22%；扣非归母净利润同比增长54.72%；毛利率提升至60.52%。公司二季度归母净利润出现阶段性亏损，系呼吸系统用药季节性淡季所致；上半年整体净利润仍同比增长45%，管理费用与销售费用同比下降，研发投入保持稳定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0239","300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666733675","title":"金石亚药：9月11日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2666733675","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666733675?lang=zh_cn&edition=full","pubTime":"2026-09-11 23:06","pubTimestamp":1789139189,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月11日金石亚药发布公告称公司于2026年9月11日召开业绩说明会。2026 年 8 月，公司产品双氯芬酸钠缓释片中选第十二批国家组织药品集中带量采购。公司当前经营稳健，上半年归母净利润 9,547.42 万元，同比增长 45.22%，扣非归母净利润增长54.72%，毛利率提升至 60.52%，降本增效成效明显。公司二季度归母净利润出现阶段性亏损。金石亚药主营业务：医药健康和新材料与机械。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300434","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232942","title":"金石亚药（300434）披露将参加四川辖区2026年投资者网上集体接待日及半年度报告业绩说明会活动，9月8日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232942","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665232942?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:53","pubTimestamp":1788861205,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，金石亚药报收于11.16元，较前一交易日上涨0.36%，最新总市值为44.83亿元。该股当日开盘11.1元，最高11.22元，最低10.92元，成交额达2.08亿元，换手率为5.46%。金石亚药近日披露《关于参加四川辖区2026年投资者网上集体接待日及半年度报告业绩说明会活动的公告》。公司高管将就公司2025年度及2026年半年度业绩、公司治理、发展战略和经营状况等与投资者进行沟通交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800027844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300434","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664054978","title":"股市必读：金石亚药新发布《关于董事减持计划期限届满的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664054978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664054978?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:14","pubTimestamp":1788455653,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，金石亚药报收于11.12元，下跌2.2%，换手率3.74%，成交量12.83万手，成交额1.43亿元。当日关注点交易信息汇总：9月3日主力资金净流入742.15万元，占总成交额5.2%。公司公告汇总：董事郑志勇减持计划期限届满，累计减持550,000股，占总股本0.14%，减持均价11.26元/股。减持后持有公司股份2,915,304股，占总股本0.72%。本次减持已按计划预披露并合规实施，未导致公司控制权变更，不影响公司治理及持续经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400001793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0239","300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664775817","title":"金石亚药（300434）披露董事减持计划期限届满公告，9月2日股价上涨0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664775817","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664775817?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:27","pubTimestamp":1788359234,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，金石亚药报收于11.37元，较前一交易日上涨0.53%，最新总市值为45.68亿元。该股当日开盘11.31元，最高11.5元，最低11.1元，成交额达1.57亿元，换手率为4.03%。近日，金石亚药发布《关于董事减持计划期限届满的公告》。减持后持有公司股份2,915,304股，占总股本0.72%。本次减持已按计划预披露并合规实施，未导致公司控制权变更，不影响公司治理及持续经营。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200042998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300434","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664789851","title":"金石亚药：8月31日董事郑志勇减持股份合计5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664789851","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664789851?lang=zh_cn&edition=full","pubTime":"2026-09-01 21:02","pubTimestamp":1788267751,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月1日市场公开信息、上市公司公告及交易所披露数据整理，金石亚药（300434）最新董监高及相关人员股份变动情况：2026年8月31日公司董事郑志勇共减持公司股份5.0万股，占公司总股本为0.0124%。变动期间公司股价下跌3.57%，8月31日当日收盘报11.07元。金石亚药近半年内的董监高及核心技术人员增减持详情如下：金石亚药的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、金石亚药公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100040425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300434","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005972","title":"金石亚药：8月28日董事郑志勇减持股份合计15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005972","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663005972?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:01","pubTimestamp":1788181293,"startTime":"0","endTime":"0","summary":"证券之星消息，根据8月31日市场公开信息、上市公司公告及交易所披露数据整理，金石亚药（300434）最新董监高及相关人员股份变动情况：2026年8月28日公司董事郑志勇共减持公司股份15.0万股，占公司总股本为0.0373%。变动期间公司股价下跌2.46%，8月28日当日收盘报11.48元。金石亚药近半年内的董监高及核心技术人员增减持详情如下：金石亚药的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、金石亚药公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100034716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0077","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728199","title":"金石亚药（300434）2026年中报简析：净利润同比增长45.22%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662728199?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:46","pubTimestamp":1787784379,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期金石亚药发布2026年中报。截至本报告期末，公司营业总收入4.91亿元，同比下降0.22%，归母净利润9547.42万元，同比上升45.22%。本报告期金石亚药盈利能力上升，毛利率同比增幅6.38%，净利率同比增幅47.55%。筹资活动产生的现金流量净额变动幅度为86.24%,原因:派发现金股利及借款等影响。然而去年的净利率为12.39%，算上全部成本后，公司产品或服务的附加值高。本文数据来源于金石亚药2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700013347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735366","title":"图解金石亚药中报：第二季度单季净利润同比下降809.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662735366?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:20","pubTimestamp":1787653242,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药2026年中报显示，上半年度公司主营收入4.91亿元，同比下降0.22%；归母净利润9547.42万元，同比上升45.22%；扣非净利润8621.65万元，同比上升54.72%；其中2026年第二季度，公司单季度主营收入1.59亿元，同比下降20.53%；单季度归母净利润-2054.15万元，同比下降809.77%；单季度扣非净利润-2322.87万元，同比下降1057.23%；负债率15.8%，投资收益-17.5万元，财务费用112.37万元，毛利率60.52%。财报数据概要请见下图:本文数据来源于金石亚药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500038955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273826","title":"金石亚药(300434)6月30日股东户数2.91万户，较上期增加21.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273826","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662273826?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:53","pubTimestamp":1787651583,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金石亚药披露，截至2026年6月30日公司股东户数为2.91万户，较3月31日增加5148.0户，增幅为21.53%。在化学制药行业个股中，金石亚药股东户数低于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.68万户。从股价来看，2026年3月31日至2026年6月30日，金石亚药区间涨幅为14.44%，在此期间股东户数增加5148.0户，增幅为21.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500037672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300434","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658387931","title":"金石亚药：8月7日董事郑志勇减持股份合计25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658387931","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658387931?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:01","pubTimestamp":1786366891,"startTime":"0","endTime":"0","summary":"证券之星消息，根据8月10日市场公开信息、上市公司公告及交易所披露数据整理，金石亚药（300434）最新董监高及相关人员股份变动情况：2026年8月7日公司董事郑志勇共减持公司股份25.0万股，占公司总股本为0.0622%。变动期间公司股价上涨8.84%，8月7日当日收盘报11.45元。金石亚药近半年内的董监高及核心技术人员增减持详情如下：金石亚药的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、金石亚药公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000031732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","300434","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657417563","title":"股市必读：金石亚药新发布《关于子公司参与第十二批全国药品集中采购拟中选的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657417563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657417563?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:05","pubTimestamp":1785866716,"startTime":"0","endTime":"0","summary":"公司公告汇总：全资二级子公司浙江迪耳药业双氯芬酸钠缓释片拟中选第十二批全国药品集采，2025年度拟中选规格销售收入622.31万元，占公司当期营收0.60%。公司公告汇总关于子公司参与第十二批全国药品集中采购拟中选的公告四川金石亚洲医药股份有限公司全资二级子公司浙江迪耳药业有限公司参与第十二批国家组织药品集中带量采购，其双氯芬酸钠缓释片拟中选。目前采购协议尚未签订，后续存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0077","300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656350735","title":"金石亚药：续断壮骨胶囊属于国家中药二类新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2656350735","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656350735?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:25","pubTimestamp":1785831928,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的领导您好！公司已研发成功上市“续断壮骨胶囊”是国家中药二类新药吗？主要是用于什么症状？在中药管线储备方面，我们有开展计划吗？谢谢！金石亚药回复：尊敬的投资者，您好！目前，公司已上市的在销产品“续断壮骨胶囊”属于国家中药二类新药，适应症及功效为补肾壮骨，用于原发性骨质疏松症属肝肾不足证。公司目前在研项目相关情况请详见公司定期报告。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400027166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300434","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652428603","title":"金石亚药（300434）披露放弃参股公司增资优先认购权暨关联交易公告，7月17日股价下跌7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652428603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652428603?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:10","pubTimestamp":1784297432,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，金石亚药报收于10.91元，较前一交易日下跌7.62%，最新总市值为43.83亿元。近日，金石亚药披露《关于放弃参股公司增资优先认购权暨关联交易的公告》。公告显示，公司于2026年7月17日召开董事会，审议通过放弃参股公司杭州领业医药科技有限公司本次增资的优先认购权。公司原持有领业医药32.43%股权，放弃认购后持股比例被动稀释至30.12%。关联董事已回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700044611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0239","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651830244","title":"股市必读：金石亚药（300434）预计2026年1-6月扣非后净利润盈利7612.6万元至9861.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651830244","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651830244?lang=zh_cn&edition=full","pubTime":"2026-07-15 02:22","pubTimestamp":1784053330,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，金石亚药报收于11.85元，下跌0.75%，换手率10.88%，成交量37.22万手，成交额4.36亿元。业绩披露要点业绩预告金石亚药发布业绩预告，预计2026年1-6月扣非后净利润盈利7612.6万元至9861.96万元；归属净利润盈利8606.25万元至1.09亿元。公司公告汇总2026年半年度业绩预告四川金石亚洲医药股份有限公司预计2026年上半年归属于上市公司股东的净利润为8,606.25万元至10,855.61万元，同比增长30.90%至65.12%；扣除非经常性损益后的净利润为7,612.60万元至9,861.96万元，同比增长36.61%至76.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104243","title":"金石亚药（300434）披露2026年半年度业绩预告，7月14日股价下跌0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104243","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651104243?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:33","pubTimestamp":1784039592,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，金石亚药报收于11.85元，较前一交易日下跌0.75%，最新总市值为47.61亿元。该股当日开盘11.95元，最高12.09元，最低11.1元，成交额达4.36亿元，换手率为10.88%。近日，四川金石亚洲医药股份有限公司披露2026年半年度业绩预告。本次业绩预告未经审计，最终数据以2026年半年度报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651178982","title":"金石亚药：创业板上市公司半年度业绩预告无强制披露要求","url":"https://stock-news.laohu8.com/highlight/detail?id=2651178982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651178982?lang=zh_cn&edition=full","pubTime":"2026-07-14 15:39","pubTimestamp":1784014745,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司什么时候发业绩中报预告？金石亚药回复：尊敬的投资者，您好！根据相关监管规则，创业板上市公司半年度业绩预告无强制披露要求，公司将结合经营数据，综合考量是否披露相关业绩预告。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400024881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300434","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649399642","title":"金石亚药：目前，公司没有上述产品的获批事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2649399642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649399642?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:27","pubTimestamp":1783326445,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)07月06日在投资者关系平台上答复投资者关心的问题。投资者提问：子公司亚洲制药儿童布洛芬混悬液通过美国FDA仿制药认证，可直接在美国市场销售。这个事情是否是真的？为何在广发，东方财富，都没有看到公司发公告？金石亚药回复：尊敬的投资者，您好！目前，公司没有上述产品的获批事项。在研项目如果有实质性进展，公司将会严格按照相关要求履行信息披露义务。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600021839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0239","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647292023","title":"6月29日金石亚药（300434）涨停分析：医保目录预期、FDA获批驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2647292023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647292023?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:36","pubTimestamp":1782718570,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药6月29日涨停收盘，收盘价10.81元。该股于13点3分涨停，未打开涨停，截止收盘封单资金为1.05亿元，占其流通市值2.84%。6月29日金石亚药涨停的可能因素有：公司于6月27日公告其核心产品“快克”入选2024年国家医保目录谈判范围，市场预期终端放量提升；同期披露子公司亚洲制药获FDA关于布洛芬混悬液ANDA批准，出海进展获关注；此外，近期多家券商发布深度报告，强调其OTC渠道优势及儿科用药细分赛道壁垒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900017491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0077","300434"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789632902169,"stockEarnings":[{"period":"1week","weight":-0.0432},{"period":"1month","weight":-0.1652},{"period":"3month","weight":0.158},{"period":"6month","weight":0.0774},{"period":"1year","weight":0.0494},{"period":"ytd","weight":0.0219}],"compareEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":-0.0229},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0165},{"period":"1year","weight":0.0077},{"period":"ytd","weight":-0.0195}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川金石亚洲医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"29059人(较上一季度增加21.53%)","perCapita":"11816股","listingDate":"2015-04-24","address":"四川省成都市双流区九江镇万家社区","registeredCapital":"40174万元","survey":" 四川金石亚洲医药股份有限公司的主营业务是药品及保健食品研发、生产以及销售。公司的主要产品是呼吸系统用药、其他医药健康产品、保健品及食品等领域。公司获得了“最受药店欢迎的明星单品”奖、浙江快克荣获“第二十届中国品牌节TopBrand2026中国品牌500强”等荣誉。","listedPrice":10.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金石亚药,300434,金石亚药股票,金石亚药股票老虎,金石亚药股票老虎国际,金石亚药行情,金石亚药股票行情,金石亚药股价,金石亚药股市,金石亚药股票价格,金石亚药股票交易,金石亚药股票购买,金石亚药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}